Immunotherapy
-
Future Beyond Cancer: What Makes Biden's Cancer Moonshot A Massive Breakthrough?
-
Federal Panel Approves First Human Clinical Trial For Controversial Gene-Editing Tool CRISPR
-
Bladder Cancer Drug Atezolizumab Proved To Be Effective As Initial Treatment
-
Up To 25 Percent Of Lung Cancer Patients Ineligible For Immunotherapy
-
FDA Approves New Immunotherapy Medication For Blood, Bladder Cancers
-
Jimmy Carter's Immune Drug Keytruda Helps Cancer Patients Live Three Years Longer
-
93 Percent Of Advanced Leukemia Patients In Remission After Receiving Immunotherapy
-
Immunotherapy Drug Combo Eliminates 20 Percent Of Tumors
-
Immunotherapy Drug Nivolumab Increases Survival Rate Of Melanoma Patients By Up To Five Years
-
Napster Founder Sean Parker Backs Cancer Immunotherapy Consortium With $250 Million Funding
-
Immunotherapy Trial To Test New Vaccine For Terminal Cancer
-
Breakthrough Cancer Treatment Uses T-Cells To Remember And Attack Tumor Cells
Most Popular
